Editorial
doi: 10.1212/01.WNL.0000153532.80277.21.
Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis
- PMID: 15753408
- DOI: 10.1212/01.WNL.0000153532.80277.21
Item in Clipboard
Editorial
Coming of age: the use of immunomodulatory therapy in children with multiple sclerosis
Neurology.
.
No abstract available
Comment on
-
Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a.Neurology. 2005 Mar 8;64(5):888-90. doi: 10.1212/01.WNL.0000153570.33845.6A. Neurology. 2005. PMID: 15753430
Similar articles
-
Use of interferon-beta in the treatment of multiple sclerosis.Adv Neurol. 2006;98:257-71. Adv Neurol. 2006. PMID: 16400838 Review. No abstract available.
-
Interferon neutralizing antibodies in multiple sclerosis: a new perspective.Arch Neurol. 2010 Apr;67(4):386-7. doi: 10.1001/archneurol.2010.31. Arch Neurol. 2010. PMID: 20385901 No abstract available.
-
Defining multiple sclerosis treatment response with magnetic resonance imaging: how much activity is too much?Arch Neurol. 2009 Jan;66(1):19-20. doi: 10.1001/archneurol.2008.529. Arch Neurol. 2009. PMID: 19139295 No abstract available.
-
Translating new insights into treatment optimisation in multiple sclerosis.J Neurol Sci. 2009 Feb 1;277 Suppl 1:S1-2. doi: 10.1016/S0022-510X(09)70002-4. J Neurol Sci. 2009. PMID: 19200857 No abstract available.
-
The use of glatiramer acetate in the treatment of multiple sclerosis.Adv Neurol. 2006;98:273-92. Adv Neurol. 2006. PMID: 16400839 Review.
Cited by
-
Therapies for multiple sclerosis: considerations in the pediatric patient.Nat Rev Neurol. 2011 Feb;7(2):109-22. doi: 10.1038/nrneurol.2010.198. Epub 2011 Jan 11. Nat Rev Neurol. 2011. PMID: 21224883 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
